...
首页> 外文期刊>Assay and drug development technologies >Phenotypic Assays for Characterizing Compound Effects on Induced Pluripotent Stem Cell-Derived Cardiac Spheroids
【24h】

Phenotypic Assays for Characterizing Compound Effects on Induced Pluripotent Stem Cell-Derived Cardiac Spheroids

机译:表型测定,用于表征诱导多能干细胞衍生心脏球状体的复合作用

获取原文
获取原文并翻译 | 示例
           

摘要

Development of more complex, biologically relevant, and predictive cell-based assays for compound screening is a major challenge in drug discovery. The focus of this study was to establish high-throughput compatible three-dimensional (3D) cardiotoxicity assays using human induced pluripotent stem cell-derived cardiomyocytes. Using both high-content imaging and fast kinetic fluorescence imaging, the impact of various compounds on the beating rates and patterns of cardiac spheroids was monitored by changes in intracellular Ca 2+ levels with calcium-sensitive dyes. Advanced image analysis methods were implemented to provide multiparametric characterization of the Ca 2+ oscillation patterns. In addition, we used confocal imaging and 3D analysis methods to characterize compound effects on the morphology of 3D spheroids. This phenotypic assay allows for the characterization of parameters such as beating frequency, amplitude, peak width, rise and decay times, as well as cell viability and morphological characteristics. A set of 22 compounds, including a number of known cardioactive and cardiotoxic drugs, was assayed at different time points, and the calculated EC 50 values for compound effects were compared between 3D and two-dimensional (2D) model systems. A significant concordance in the phenotypes was observed for compound effects between the two models, but essential differences in the concentration responses and time dependencies of the compound-induced effects were observed. Together, these results indicate that 3D cardiac spheroids constitute a functionally distinct biological model system from traditional flat 2D cultures. In conclusion, we have demonstrated that phenotypic assays using 3D model systems are enabled for screening and suitable for cardiotoxicity assessment in vitro.]]>
机译:在复方筛选的制育更复杂,生物学相关和预测性细胞的测定是药物发现中的主要挑战。本研究的重点是使用人诱导多能干细胞衍生的心肌细胞建立高通量兼容的三维(3D)心毒性测定。使用高含量成像和快速动力学荧光成像,通过细胞内Ca 2+水平与钙敏感染料的变化监测各种化合物对心脏球状体的跳动率和模式的影响。实施先进的图像分析方法以提供CA 2+振荡模式的多次特征。此外,我们使用共聚焦成像和3D分析方法来表征对3D球状体形态的复合效应。该表型测定允许表征参数,例如跳动频率,振幅,峰宽度,上升和衰减时间,以及细胞活力和形态特征。在不同的时间点测定一组22种化合物,包括许多已知的肿瘤和心脏毒性药物,并且在3D和二维(2D)模型系统之间比较了计算出的EC 50的化合物效应的50值。在两种模型之间的复合效应中观察到表型的显着的一致性,但观察到复合诱导的效果的浓度反应和时间依赖性的基本差异。这些结果表明,3D心脏球体构成来自传统平面2D培养物的功能性独特的生物模型系统。总之,我们已经证明了使用3D模型系统的表型测定能够筛选和适用于体外心脏毒性评估。]]>

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号